Medical directoryActive ingredient
Zepbound
Brand name for higher-dose tirzepatide, approved for obesity in some countries. According to the article, it was still going through the authorisation process in the EU at the time of publication.
Institutional endorsement by Clínica Evolution
Medical guides
Orforglipron (Foundayo): the first GLP-1 pill with no restrictions, and why it isn't available in Spain
ReadRetatrutide: what its phase 3 trial found, and why you can't get hold of it
ReadCagriSema: what it is, what the REDEFINE trials found and why it disappointed
ReadGLP-1: what it is, how it works and why it is transforming obesity treatment
ReadMounjaro vs Ozempic: clinical differences, effectiveness and which one suits you
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.